Preferreds Trading at the Largest Discounts
By Preferred Stock Channel Staff, updated Tue, January 21, 6:37 AM
. Fortress Biotech Inc #25 | 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock (NASDAQ: FBIOP) | -15.08% CURRENT DISCOUNT
Discount to Liquidation Preference: -15.08% Average Discount in Category:
-4.06% Current Annualized Yield: 11.04% Average Yield in Category: 10.44% Days Since Last Ex-Div Date: 36 | See Dividend History » Categorization: Biotechnology
Series: A Redeemable?: Yes Call Date: 12/15/2022 Perpetual?: Yes Cumulative?: Yes Shares Offered: 1,000,000 Overallotment: 150,000 Liquidation Preference: $25 Recent Market Price: $21.23 Discount to Liquidation Preference: ( More Preferreds Trading at a Discount ») $-3.77 (-15.08%) Annualized Dividend: 2.34375 Recent Ex-Date: 12/12/2019 Current Yield: 11.04% Original Coupon: 9.38% Pay Period: Quarterly Pay Dates: 31-Mar, 30-Jun, 30-Sep, 31-Dec
Fortress Biotech is a biopharmaceutical company focused on acquiring, developing and commercializing pharmaceutical and biotechnology products. Co.'s product candidates include: MB-107 (XSCID), an ex vivo lentiviral gene therapy for the treatment of X-linked severe combined immunodeficiency; Intravenous Tramadol, for the treatment of moderate to moderately severe post-operative pain; and CUTX-101, a copper histidinate injection for the treatment of Menkes disease. Co.'s other product candidates include: ConVax, CEVA-101, CEVA-D and CEVA-102, TAMID-001, AVTS-001, CNDO-109 and Methazalomide.
Preferred: FBIOP Open the FBIO Information Page »
Fortress Biotech Inc
Number of ETFs Holding FBIO:
4 ( see which ones)
Total Market Value Held by ETFs:
Total Market Capitalization:
% of Market Cap. Held by ETFs:
Quotes delayed 20 minutes
Preferreds Trading at the Largest Discounts - Slide 1 of 25 | www.PreferredStockChannel.com
Copyright © 2010 - 2020, All Rights Reserved
Nothing in Preferred Stock Channel is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
minutes; data powered by Ticker Technologies, and Mergent. Contact Preferred Stock Channel; Meet Our Editorial Staff.